Related references
Note: Only part of the references are listed.Prognostic bioindicators in severe COVID-19 patients
L. Bergantini et al.
CYTOKINE (2021)
Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease
Elizabeth R. Volkmann et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2021)
The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
Hua Ma et al.
BMC PULMONARY MEDICINE (2020)
Serum KL-6 levels in pulmonary Langerhans' cell histiocytosis
Miriana d'Alessandro et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
Martina Bonifazi et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases A meta-analysis
Danli Zhong et al.
MEDICINE (2020)
Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
Miriana d'Alessandro et al.
BIOMARKERS IN MEDICINE (2020)
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseases
Laura Bergantini et al.
IMMUNOLOGIC RESEARCH (2020)
Systematic review and meta analysis Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review
Martina Orlandi et al.
RHEUMATOLOGY (2020)
Therapeutic molecular targets of SSc-ILD
Yun Zhang et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Natural history of systemic sclerosis-related interstitial lung disease: How to identify a progressive fibrosing phenotype
Elizabeth R. Volkmann
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Pathogenesis of systemic sclerosis associated interstitial lung disease
Svetlana Nihtyanova et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6
Laura Bergantini et al.
DISEASE MARKERS (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis What should the rheumatologist do?
Elena Bargagli et al.
MEDICINE (2019)
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18
Elizabeth R. Volkmann et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
Jeong Seok Lee et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Vincent Cottin et al.
RESPIRATORY RESEARCH (2019)
Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib
Laura Bergantini et al.
RESPIRATORY INVESTIGATION (2019)
KL-6 But Not CCL-18 Is a Predictor of Early Progression in Systemic Sclerosis-related Interstitial Lung Disease
Gloria A. Salazar et al.
JOURNAL OF RHEUMATOLOGY (2018)
Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease
Audrey Benyamine et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Major lung complications of systemic sclerosis
Christopher P. Denton et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity
Elena Bargagli et al.
PATHOBIOLOGY (2018)
Radiologic pleuroparenchymal fibroelastosis-like lesion in connective tissue disease-related interstitial lung disease
Yasunori Enomoto et al.
PLOS ONE (2017)
Silicosis en trabajadores expuestos a conglomerados artificiales de cuarzo: ¿es distinta a la silicosis crónica simple?
Valentina Paolucci et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?
Takeshi Nakatani et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Pleuroparenchymal fibroelastosis: a pattern of chronic lung injury
Jason N. Rosenbaum et al.
HUMAN PATHOLOGY (2015)
Silicosis en trabajadores expuestos a conglomerados artificiales de cuarzo: ¿es distinta a la silicosis crónica simple?
Valentina Paolucci et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
Eric W. F. W. Alton et al.
LANCET RESPIRATORY MEDICINE (2015)
Distinct Characteristics of Pleuroparenchymal Fibroelastosis With Usual Interstitial Pneumonia Compared With Idiopathic Pulmonary Fibrosis
Tsuneyuki Oda et al.
CHEST (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Clinical Features and Outcomes in Combined Pulmonary Fibrosis and Emphysema in Idiopathic Pulmonary Fibrosis
Christopher J. Ryerson et al.
CHEST (2013)
Utility of spiral CAT scan in the follow-up of patients with pulmonary Langerhans cell histiocytosis
M. Abbritti et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
Taryn L. Reddy et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
K. M. Antoniou et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma
Faye N. Hant et al.
JOURNAL OF RHEUMATOLOGY (2009)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
How much do GOLD stages reflect CT abnormalities in COPD patients?
M. Pescarolo et al.
RADIOLOGIA MEDICA (2008)
Pulmonary disease assessment in cystic fibrosis:: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements
PA de Jong et al.
RADIOLOGY (2004)
Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases
H Ohnishi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Share Paper
